NASDAQ : ALT
Altimmune, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 396.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Altimmune, Inc. (ALT) reported revenue of 31.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 31.00K | 41.00K | 20.00K | 426.00K | -68.00K | 4.41M |
| Cost of Revenue | 66.72M | 66.43M | 82.23M | 65.80M | 70.45M | 73.84M |
| Gross Profit | -66.69M | -66.39M | -82.21M | -65.37M | -70.52M | -69.43M |
| Selling, General & Admin | 32.04M | 28.10M | 20.97M | 18.14M | 17.13M | 15.41M |
| Operating Expenses | 32.04M | 28.10M | 20.97M | 18.14M | 17.13M | 15.41M |
| Operating Income | -98.73M | -94.49M | -103.17M | -83.51M | -87.65M | -84.84M |
| Interest Expense | -3.54M | -1.64M | -9.00K | -35.00K | -8.00K | -5.00K |
| Interest & Investment Income | 12.29M | 7.54M | 8.07M | 7.35M | 2.87M | 203.00K |
| Other Non Operating Income (Expenses) | -290.00K | -190.00K | 48.00K | 166.00K | -32.00K | -374.00K |
| EBT Excluding Unusual Items | -90.27M | -88.77M | -95.06M | -76.03M | -84.82M | -85.02M |
| Asset Writedown | -1.49M | -12.42M | -11.37M | |||
| Other Unusual Items | -86.00K | -700.00K | ||||
| Pretax Income | -91.76M | -88.77M | -95.06M | -88.45M | -84.91M | -97.09M |
| Income Tax Expense | -681.00K | -197.00K | ||||
| Net Income | -91.76M | -88.09M | -95.06M | -88.45M | -84.71M | -97.09M |
| Net Income to Common | -91.76M | -88.09M | -95.06M | -88.45M | -84.71M | -97.09M |
| Shares Outstanding (Basic) | 126.40M | 88.10M | 71.00M | 53.25M | 46.93M | 41.28M |
| Shares Outstanding (Diluted) | 126.40M | 88.10M | 71.00M | 53.25M | 46.93M | 41.28M |
| EPS (Basic) | -0.73 | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| EPS (Diluted) | -0.73 | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| Free Cash Flow | -76.56M | -67.55M | -79.85M | -75.86M | -62.71M | -90.36M |
| Free Cash Flow Per Share | -0.61 | -0.77 | -1.12 | -1.43 | -1.34 | -2.19 |
| Operating Margin | -318,493.55% | -230,460.98% | -515,860.00% | -19,603.29% | -1,923.90% | |
| Profit Margin | -296,000.00% | -214,860.98% | -475,295.00% | -20,762.21% | -2,201.59% | |
| Free Cash Flow Margin | -246,974.19% | -164,746.34% | -399,240.00% | -17,806.81% | -2,048.87% | |
| EBITDA | -98.63M | -94.38M | -102.93M | -83.03M | -87.16M | -84.29M |
| D&A For EBITDA | 99.00K | 112.00K | 238.00K | 477.00K | 493.00K | 551.00K |
| EBIT | -98.73M | -94.49M | -103.17M | -83.51M | -87.65M | -84.84M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 63.01M | 43.76M | 36.93M | 135.12M | 111.10M | 190.30M |
| Short-Term Investments | 263.27M | 229.70M | 94.97M | 62.70M | 73.78M | |
| Cash & Short-Term Investments | 326.28M | 273.46M | 131.89M | 197.81M | 184.88M | 190.30M |
| Accounts Receivable | 41.00K | 1.22M | 544.00K | 1.11M | 173.00K | 429.00K |
| Other Receivables | 3.30M | 518.00K | 2.57M | 3.74M | 2.37M | 5.41M |
| Receivables | 3.34M | 1.74M | 3.12M | 4.85M | 2.54M | 5.84M |
| Prepaid Expenses | 4.95M | 2.76M | 2.20M | 6.92M | 5.36M | 7.95M |
| Restricted Cash | 42.00K | 42.00K | 42.00K | 41.00K | 34.00K | 34.00K |
| Other Current Assets | 200.00K | 200.00K | ||||
| Total Current Assets | 334.81M | 278.19M | 137.25M | 209.63M | 192.81M | 204.13M |
| Property, Plant & Equipment | 150.00K | 1.74M | 2.05M | 1.01M | 1.68M | 2.25M |
| Other Intangible Assets | 12.42M | 12.42M | ||||
| Other Long-Term Assets | 19.00K | 74.00K | ||||
| Total Assets | 527.21M | 279.93M | 139.31M | 210.64M | 206.93M | 218.87M |
| Accounts Payable | 1.27M | 2.72M | 211.00K | 2.07M | 4.80M | 2.03M |
| Accrued Expenses | 10.96M | 12.02M | 9.98M | 9.58M | 10.63M | 9.74M |
| Current Portion of Leases | 274.00K | 256.00K | 279.00K | 496.00K | 452.00K | 411.00K |
| Current Income Taxes Payable | 1.17M | |||||
| Other Current Liabilities | 6.09M | |||||
| Total Current Liabilities | 12.50M | 15.00M | 10.47M | 12.14M | 17.05M | 18.28M |
| Long-Term Debt | 34.74M | 34.29M | ||||
| Long-Term Leases | 1.00M | 1.15M | 1.40M | 175.00K | 672.00K | 1.12M |
| Long-Term Unearned Revenue | 147.00K | 160.00K | 160.00K | 160.00K | 250.00K | 250.00K |
| Other Long-Term Liabilities | 4.61M | 4.45M | 3.77M | 4.06M | 3.66M | 80.00K |
| Total Liabilities | 53.00M | 55.04M | 15.80M | 16.54M | 21.64M | 19.73M |
| Common Stock | 19.00K | 11.00K | 7.00K | 7.00K | 5.00K | 4.00K |
| Additional Paid-In Capital | 1.18B | 879.29M | 689.86M | 665.43M | 568.40M | 497.34M |
| Retained Earnings | -694.87M | -649.48M | -561.39M | -466.33M | -377.88M | -293.17M |
| Comprehensive Income & Other | -6.04M | -4.93M | -4.97M | -5.00M | -5.23M | -5.04M |
| Total Common Equity | 474.21M | 224.89M | 123.51M | 194.10M | 185.29M | 199.13M |
| Shareholders' Equity | 474.21M | 224.89M | 123.51M | 194.10M | 185.29M | 199.13M |
| Total Liabilities & Equity | 527.21M | 279.93M | 139.31M | 210.64M | 206.93M | 218.87M |
| Total Debt | 36.02M | 35.69M | 1.68M | 671.00K | 1.12M | 1.53M |
| Net Cash (Debt) | 290.26M | 237.77M | 130.21M | 197.14M | 183.76M | 188.77M |
| Net Cash Per Share | 2.30 | 2.70 | 1.83 | 3.70 | 3.92 | 4.57 |
| Filing Date Shares Outstanding | 194.52M | 130.07M | 77.01M | 70.90M | 49.28M | 42.92M |
| Total Common Shares Outstanding | 194.47M | 110.88M | 72.35M | 70.68M | 49.20M | 40.69M |
| Working Capital | 322.31M | 263.19M | 126.79M | 197.48M | 175.76M | 185.85M |
| Book Value Per Share | 2.44 | 2.03 | 1.71 | 2.75 | 3.77 | 4.89 |
| Tangible Book Value | 474.21M | 224.89M | 123.51M | 194.10M | 172.87M | 186.72M |
| Tangible Book Value Per Share | 2.44 | 2.03 | 1.71 | 2.75 | 3.51 | 4.59 |
| Machinery | 710.00K | 699.00K | 699.00K | 652.00K | 1.55M | |
| Leasehold Improvements | 1.75M | 1.75M | 1.75M | 1.75M | 1.79M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -91.76M | -88.09M | -95.06M | -88.45M | -84.71M | -97.09M |
| Depreciation & Amortization | 99.00K | 112.00K | 238.00K | 477.00K | 493.00K | 551.00K |
| Other Amortization | 397.00K | |||||
| Asset Writedown & Restructuring Costs | 1.49M | 12.42M | 11.95M | |||
| Loss (Gain) From Sale of Investments | -2.96M | -2.22M | -3.85M | -2.47M | -698.00K | |
| Stock-Based Compensation | 14.66M | 16.08M | 14.39M | 10.64M | 8.10M | 5.52M |
| Other Operating Activities | 669.00K | -158.00K | -48.00K | -154.00K | 120.00K | 1.08M |
| Change in Accounts Receivable | -3.02M | -675.00K | 567.00K | -938.00K | 256.00K | 4.18M |
| Change in Accounts Payable | 421.00K | 2.51M | -1.86M | -2.73M | 2.77M | 1.42M |
| Change in Income Taxes | 557.00K | 2.74M | 1.17M | -1.37M | 3.04M | 2.35M |
| Change in Other Net Operating Assets | 2.94M | 2.19M | 4.60M | -3.23M | 8.04M | -8.21M |
| Operating Cash Flow | -76.51M | -67.53M | -79.85M | -75.81M | -62.59M | -78.24M |
| Capital Expenditures | -54.00K | -11.00K | -47.00K | -126.00K | -12.12M | |
| Sale (Purchase) of Intangibles | -195.00K | |||||
| Investment in Securities | -453.56M | -132.46M | -28.39M | 13.78M | -73.27M | 99.83M |
| Investing Cash Flow | -453.61M | -132.47M | -28.39M | 13.73M | -73.40M | 87.52M |
| Long-Term Debt Issued | 35.00M | |||||
| Total Debt Issued | 20.40M | 35.00M | ||||
| Net Debt Issued (Repaid) | 20.40M | 35.00M | ||||
| Issuance of Common Stock | 391.85M | 174.06M | 10.89M | 86.93M | 57.30M | 65.22M |
| Repurchase of Common Stock | -709.00K | -709.00K | -850.00K | -539.00K | -516.00K | |
| Other Financing Activities | -1.52M | -1.51M | -285.00K | -118.00K | ||
| Financing Cash Flow | 410.02M | 206.84M | 10.04M | 86.11M | 56.78M | 65.10M |
| Net Cash Flow | -120.10M | 6.83M | -98.19M | 24.03M | -79.20M | 74.38M |
| Free Cash Flow | -76.56M | -67.55M | -79.85M | -75.86M | -62.71M | -90.36M |
| Free Cash Flow Margin | -246,974.19% | -164,746.34% | -399,240.00% | -17,806.81% | -2,048.87% | |
| Free Cash Flow Per Share | -0.61 | -0.77 | -1.12 | -1.43 | -1.34 | -2.19 |
| Levered Free Cash Flow | -48.79M | -38.72M | -44.87M | -49.98M | -41.69M | -52.56M |
| Unlevered Free Cash Flow | -46.58M | -37.70M | -44.86M | -49.96M | -41.69M | -52.56M |
| Cash Interest Paid | 2.61M | 975.00K | ||||
| Cash Income Tax Paid | 2.84M | 1.42M | ||||
| Change in Working Capital | 895.00K | 6.75M | 4.48M | -8.27M | 14.11M | -251.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 396.82M | 394.05M | 512.81M | 604.45M | 808.45M | 363.14M |
| Enterprise Value | 106.56M | 199.18M | 375.20M | 464.46M | 607.85M | 164.89M |
| Last Close Price | 2.04 | 3.61 | 7.21 | 11.25 | 16.45 | 9.16 |
| Forward PE | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | |
| PS Ratio | 12,800.52 | 9,610.97 | 25,640.43 | 1,418.90 | -11,888.90 | 82.34 |
| PB Ratio | 0.84 | 1.75 | 4.15 | 3.11 | 4.36 | 1.82 |
| P/TBV Ratio | 0.84 | 1.75 | 4.15 | 3.11 | 4.68 | 1.95 |
| EV/Sales Ratio | 3,437.26 | 4,858.01 | 18,760.08 | 1,090.28 | 37.39 | |
| Debt / Equity Ratio | 0.08 | 0.16 | 0.01 | 0.00 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -0.61 | -1.06 | -1.05 | -1.02 | -0.99 | -0.95 |
| Net Debt / EBITDA Ratio | 2.94 | 2.52 | 1.26 | 2.37 | 2.11 | 2.24 |
| Net Debt / FCF Ratio | 3.79 | 3.52 | 1.63 | 2.60 | 2.93 | 2.09 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Quick Ratio | 26.37 | 18.35 | 12.90 | 16.69 | 10.99 | 10.73 |
| Current Ratio | 26.78 | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 |
| Return on Equity (ROE) | -28.88% | -50.57% | -59.86% | -46.63% | -44.07% | -45.69% |
| Return on Assets (ROA) | -17.20% | -28.17% | -36.85% | -25.00% | -25.73% | -22.86% |
| Return on Capital Employed (ROCE) | -19.20% | -35.70% | -80.10% | -42.10% | -46.20% | -42.30% |
| Earnings Yield | -35.59% | -22.36% | -18.54% | -14.63% | -10.48% | -26.74% |
| FCF Yield | -19.29% | -17.14% | -15.57% | -12.55% | -7.76% | -24.88% |
| Buyback Yield / Dilution | -68.90% | -24.08% | -33.35% | -13.47% | -13.67% | -61.03% |